Journey Medical Corp (DERM) Return on equity 2020–2025
Journey Medical Corp (DERM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-35.9%FY2025 · since FY2020: 51.3% → -35.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -35.9% | +37.2 pp |
| FY2024 | -73.1% | -54.2 pp |
| FY2023 | -18.9% | +155.5 pp |
| FY2022 | -174.5% | -69.8 pp |
| FY2021 | -104.6% | -156.0 pp |
| FY2020 | 51.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More DERM financial trends
DERM RevenueDERM Net incomeDERM Net marginDERM Gross profitDERM Gross marginDERM Operating incomeDERM Operating marginDERM Operating cash flowDERM Free cash flowDERM Capital expendituresDERM Stock buybacksDERM Dividends paidDERM Total assetsDERM Total liabilitiesDERM Shareholders’ equityDERM overview →